search

greenelab / covid19-review

A collaborative review of the emerging COVID-19 literature. Join the chat here:
https://gitter.im/covid19-review/community
Other
116 stars 81 forks source link

New Paper (Other): SARS and MERS: Recent insights into emerging coronaviruses #54

Open rando2 opened 4 years ago

rando2 commented 4 years ago

Paper Background

Please paste a link to the paper or a citation here:

https://doi.org/f8v5cv

What is the paper's DOI?

DOI: 10.1038/nrmicro.2016.81

Is this paper primarily relevant to Background or Pathogenesis? (If it is primarily relevant to diagnostics or therapeutics, please go back and use the correct template)

Please list some keywords (3-10) that help identify the relevance of this paper to COVID-19

Which areas of expertise are particularly relevant to the paper (put an x in the brackets [x])?

Suggested Reviewers (feel free to suggest yourself)

@rmrussell (who initially added this citation in #27 )

-------------------------------------------------------------------------------------------------------- # Questions for Reviewers to Address Reviewers, please copy and paste the section below into a comment and fill it in. ## Suggested questions to answer about each paper: - What did they analyze? - What methods did they use? - Does this paper study COVID-19, SARS-CoV-2, or a related disease and/or virus? - What is the main finding (or a few main takeaways)? - What does this paper tell us about the background and/or diagnostics/therapeutics for COVID-19 / SARS-CoV-2? - Do you have any concerns about methodology or the interpretation of these results beyond this analysis? ## Any comments or notes?
aadattoli commented 4 years ago

Hi, I am for sure interested, just wanted to know whether there is a template that I can modify/add sections and so on...sorry I am new to this system!ehehe

aadattoli commented 4 years ago

Dear All,

I edited the section about treatments and I added the tolicizumab drug analysis/description with relative literature. I am now working on the antiviral section. Can you guys see my changes? Please let me know your feedback.

agitter commented 4 years ago

@aadattoli yes we see the changes in #75. I left a couple initial formatting suggestions and then someone else can help review the content.

eberwine commented 4 years ago

Hi Ada, I wonder if there is any literature on combinatorial use of the drugs you highlight in the review for other diseases or indications. I will see what I can find.

aadattoli commented 4 years ago

Dear Jim, yes you are right, there are evidence of IFN-beta being more effective in combination with lopinavir, ritonavir and ribravin. I will add it.